首页> 外文期刊>American Journal of Epidemiology >Network Meta-Analysis: Evidence Synthesis With Mixed Treatment Comparison Edited by Giuseppe Biondi-Zoccai
【24h】

Network Meta-Analysis: Evidence Synthesis With Mixed Treatment Comparison Edited by Giuseppe Biondi-Zoccai

机译:网络荟萃分析:通过Giuseppe Biondi-Zoccai编辑的混合处理的证据合成

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Systematic reviews and meta-analyses, being at the intersection of clinical medicine, epidemiology, statistics, and translational research, are key methodologies for the practice of evidence-based medicine (1, 2). Traditional meta-analytical methods, however, pertain to pairwise comparisons between 2 interventions, thus only partially providing evidence that patients, clinicians, and policy-makers need in order to make informed decisions or public health recommendations regarding prevention, screening, diagnosis, and treatment. Questions similar to the following are often encountered in clinical practice. When there are direct (i.e., head-to-head) comparisons for only a few of the numerous biological agents for the treatment of rheumatoid arthritis, which one will have the greatest benefit in relieving joint pain? Which of the dozens of antidepressants are more likely to be effective in comparison with all other drugs in improving the symptoms of depression; are all of them equal, or is there a ranking as far as their effectiveness and safety profiles are concerned?
机译:系统的评价和荟萃分析,处于临床医学,流行病学,统计和翻译研究,是循证医学实践的关键方法(1,2)。然而,传统的荟萃分析方法涉及2个干预措施之间的成对比较,因此仅部分提供患者,临床医生和政策制定者所需的证据,以便为预防,筛查,诊断和治疗做出明智的决定或公共卫生建议。临床实践中通常遇到类似于以下内容的问题。当有直接(即,头部到头)比较,只有少数生物药物治疗类风湿性关节炎,其中一个人将在缓解关节疼痛方面具有最大的益处?与所有其他药物在改善抑郁症症状方面的比较相比,几十只抗抑郁药中的哪一种更有能力;所有这些都是平等的,或者在有关效力和安全概况时,还有排名吗?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号